Maintate and megakaryocytes decreased Patient Reports February 12, 2012



Maintate Side Effects Report #5661617-X
Maintate side effect was reported by a Physician from JAPAN on Mar 03, 2008. Female patient, 68 years of age, weighting 141.1 lb, was diagnosed with hypertension, lipids abnormal, lacunar infarction and was treated with Maintate. After drug was administered, patient experienced the following side effects: anti-platelet antibody positive, bleeding time prolonged, blood pressure increased, epistaxis, haemoptysis, haemorrhage subcutaneous, megakaryocytes decreased, platelet count decreased, thrombocytopenia. Maintate dosage: 2.5 MG/DAY. During the same period patient was treated with FLUVASTATIN, NORVASC, ASPIRIN, DIOVAN, DEPAS. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Maintate